UIME 📈 UBS SICAV - MSCI EMU Value - Overview
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU0446734369 • Eurozone Large-Cap Equity
UIME: Stocks, Bonds, Equities, European, Investments
‣ Company URL: http://www.credit-suisse.com ‣ Domicile: Luxembourg ‣ Index Name: Morningstar Dev Ezn TME NR EUR
Additional Sources for UIME ETF
UIME ETF Overview
| Market Cap in USD | 165m |
| Category | Eurozone Large-Cap Equity |
| TER | 0.25% |
| IPO / Inception | 2009-10-02 |
UIME ETF Ratings
| Growth 5y | 59.4% |
| Fundamental | - |
| Dividend | 65.0% |
| Rel. Strength Industry | 80.1 |
| Analysts | - |
| Fair Price Momentum | 44.17 EUR |
| Fair Price DCF | - |
UIME Dividends
| Dividend Yield 12m | 3.50% |
| Yield on Cost 5y | 4.81% |
| Annual Growth 5y | 13.32% |
| Payout Consistency | 91.5% |
UIME Growth Ratios
| Growth Correlation 3m | -64.8% |
| Growth Correlation 12m | 77.2% |
| Growth Correlation 5y | 89.7% |
| CAGR 5y | 7.28% |
| CAGR/Mean DD 5y | 1.02 |
| Sharpe Ratio 12m | 0.60 |
| Alpha | -7.02 |
| Beta | 0.57 |
| Volatility | 12.07% |
| Current Volume | 2k |
| Average Volume 20d | 3.4k |
What is the price of UIME stocks?
As of January 05, 2025, the stock is trading at EUR 44.16 with a total of 2,046 shares traded.
Over the past week, the price has changed by +0.23%, over one month by +0.03%, over three months by -1.14% and over the past year by +9.98%.
As of January 05, 2025, the stock is trading at EUR 44.16 with a total of 2,046 shares traded.
Over the past week, the price has changed by +0.23%, over one month by +0.03%, over three months by -1.14% and over the past year by +9.98%.
Is UBS SICAV - MSCI EMU Value a good stock to buy?
Partly, yes. Based on ValueRay Analyses, UBS SICAV - MSCI EMU Value (XETRA:UIME) is currently (January 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 59.41 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of UIME as of January 2025 is 44.17. This means that UIME is currently overvalued and has a potential downside of 0.02%.
Partly, yes. Based on ValueRay Analyses, UBS SICAV - MSCI EMU Value (XETRA:UIME) is currently (January 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 59.41 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of UIME as of January 2025 is 44.17. This means that UIME is currently overvalued and has a potential downside of 0.02%.
Is UIME a buy, sell or hold?
UBS SICAV - MSCI EMU Value has no consensus analysts rating.
UBS SICAV - MSCI EMU Value has no consensus analysts rating.
What are the forecast for UIME stock price target?
According to ValueRays Forecast Model, UIME UBS SICAV - MSCI EMU Value will be worth about 48.5 in January 2026. The stock is currently trading at 44.16. This means that the stock has a potential upside of +9.74%.
According to ValueRays Forecast Model, UIME UBS SICAV - MSCI EMU Value will be worth about 48.5 in January 2026. The stock is currently trading at 44.16. This means that the stock has a potential upside of +9.74%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 48.5 | 9.7% |